Effect of Miralax NPO Time on Residual Gastric Volumes and Bowel Preparation
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (2, 4, 6 hours) prior to anesthesia induction and compare it to the control (current institutional standard of care where no Miralax is given on the day of surgery).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Care Provider, Outcomes Assessor)
盲法说明
The endoscopist, the anesthesiologist performing the gastric POCUS evaluation, the anesthesiologist, the research coordinator
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients undergoing both EGD and colonoscopy
- •Use of Miralax for cleanout
- •Patients <19 years old
排除标准
- •Patients with a history of delayed gastric emptying (eg diabetic, GLP-1 intake)
- •Patients with a history of gastric sleeve surgery
- •Use of Golytely for cleanout
- •Emergent EGD/colonoscopies
- •EGD/colonoscopies for foreign body removal and/or decompression
- •Known neurologic compromise
- •Presence of pre-existing ostomy, short bowel syndrome, gastric retention, intestinal obstruction, ileus, bowel perforation, toxic colitis, toxic megacolon, swallowing difficulties
- •Pre-existing electrolyte derangements
- •Allergy to Miralax
研究组 & 干预措施
4hr NPO
Miralax will be stopped 4 hours prior anesthesia induction
干预措施: Stopping Miralax ingestion 4 hours prior to anesthesia induction (Behavioral)
2hr NPO
Miralax will be stopped 2 hours prior anesthesia induction
干预措施: Stopping Miralax ingestion 2 hours prior to anesthesia induction (Behavioral)
研究者
Stephanie Jiaying Pan
Clinical Associate Professor
Stanford University